Pillstats
Rx only · Solution/ Drops · Auricular (Otic)

Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone

Brands: Neomycin And Polymyxin B Sulfates And Hydrocortisone · Hydrocortisone + Neomycin Sulfate + Polymyxin B Sulfate

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8536
US makers7 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.53$3.06$4.59$6.12Dec 2025Apr 2026Jul 2026
$5.102
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
7
Active US suppliers
29%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

30K60K89K119K2025 Q12025 Q22025 Q32025 Q42026 Q1
61K
Rx · 2026 Q1
613K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Asclemed USA, Inc.unknown1SUPPLYING
Proficient Rx LPunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
Bausch & Lomb Incoporatedunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.